These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23341011)

  • 21. Psychometric properties of the Veterans Affairs Low-Vision Visual Functioning Questionnaire.
    Stelmack JA; Szlyk JP; Stelmack TR; Demers-Turco P; Williams RT; Moran D; Massof RW
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):3919-28. PubMed ID: 15505037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between visual impairment and eye diseases and visual function in Andhra Pradesh.
    Nutheti R; Keeffe JE; Shamanna BR; Nirmalan PK; Krishnaiah S; Thomas R
    Ophthalmology; 2007 Aug; 114(8):1552-7. PubMed ID: 17678693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vision and quality of life: development of methods for the VisQoL vision-related utility instrument.
    Peacock S; Misajon R; Iezzi A; Richardson J; Hawthorne G; Keeffe J
    Ophthalmic Epidemiol; 2008; 15(4):218-23. PubMed ID: 18780254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation and reliability of the VF-14 questionnaire in a German population.
    Chiang PP; Fenwick E; Marella M; Finger R; Lamoureux E
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8919-26. PubMed ID: 22025576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rasch analysis of the quality of life and vision function questionnaire.
    Gothwal VK; Wright TA; Lamoureux EL; Pesudovs K
    Optom Vis Sci; 2009 Jul; 86(7):E836-44. PubMed ID: 19521266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The longitudinal impact of macular telangiectasia (MacTel) type 2 on vision-related quality of life.
    Lamoureux EL; Maxwell RM; Marella M; Dirani M; Fenwick E; Guymer RH
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2520-4. PubMed ID: 21217104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activities of Daily Vision Scale: what do the subscales measure?
    Gothwal VK; Wright TA; Lamoureux EL; Pesudovs K
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):694-700. PubMed ID: 19684011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Visual Function Questionnaire: Utility Index: Does It Measure Glaucoma-related Preference-based Status?
    Goh RL; Fenwick E; Skalicky SE
    J Glaucoma; 2016 Oct; 25(10):822-829. PubMed ID: 27749502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The psychometric validity of the NEI VFQ-25 for use in a low-vision population.
    Marella M; Pesudovs K; Keeffe JE; O'Connor PM; Rees G; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2878-84. PubMed ID: 20089878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility values in the visually impaired: comparing time-trade off and VisQoL.
    Gothwal VK; Bagga DK
    Optom Vis Sci; 2013 Aug; 90(8):843-54. PubMed ID: 23628757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can clinicians use the PHQ-9 to assess depression in people with vision loss?
    Lamoureux EL; Tee HW; Pesudovs K; Pallant JF; Keeffe JE; Rees G
    Optom Vis Sci; 2009 Feb; 86(2):139-45. PubMed ID: 19156007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of general health status on validity of visual impairment measurement.
    Ahmadian L; Massof R
    Ophthalmic Epidemiol; 2008; 15(5):345-55. PubMed ID: 18850472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of the severity of vision loss on vision-related quality of life in India: an evaluation of the IND-VFQ-33.
    Finger RP; Kupitz DG; Holz FG; Balasubramaniam B; Ramani RV; Lamoureux EL; Fenwick E
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6081-8. PubMed ID: 21693607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validating the sumi quality of life questionnaire with rasch analysis.
    Hirasawa H; Murata H; Mayama C; Asaoka R
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(9):5776-82. PubMed ID: 24994867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rasch analysis of Impact of Vision Impairment for Children questionnaire.
    Gothwal VK; Sumalini R; Irfan SM; Giridhar A
    Optom Vis Sci; 2013 Aug; 90(8):820-7. PubMed ID: 23748842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual Activities Questionnaire: assessment of subscale validity for cataract surgery outcomes.
    Gothwal VK; Wright TA; Lamoureux EL; Pesudovs K
    J Cataract Refract Surg; 2009 Nov; 35(11):1961-9. PubMed ID: 19878830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the impact of keratoconus on vision-related quality of life.
    Gothwal VK; Reddy SP; Fathima A; Bharani S; Sumalini R; Bagga DK; Sudharman PM
    Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2902-10. PubMed ID: 23518765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiplicative rating scales do not enable measurement of vision-related quality of life.
    Gothwal VK; Wright TA; Lamoureux EL; Pesudovs K
    Clin Exp Optom; 2011 Jan; 94(1):52-62. PubMed ID: 21198834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual impairment as a function of visual acuity in both eyes and its impact on patient reported preferences.
    Finger RP; Fenwick E; Hirneiss CW; Hsueh A; Guymer RH; Lamoureux EL; Keeffe JE
    PLoS One; 2013; 8(12):e81042. PubMed ID: 24339893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rasch analysis of visual function and quality of life questionnaires.
    Gothwal VK; Wright TA; Lamoureux EL; Pesudovs K
    Optom Vis Sci; 2009 Oct; 86(10):1160-8. PubMed ID: 19741562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.